Comparing Iron Polymaltose Complex and Ferrous Sulphate to Treat Iron Deficiency Anemia in Children

What this Trial Is About

This research aims to compare the effectiveness of two commonly used iron preparations, Ferrous sulphate and Iron Polymaltose complex, for treating children with iron deficiency anemia. The study focuses on identifying which drug has better efficacy, considering differences in bioavailability, side effects, and cost. Iron deficiency anemia is a widespread condition linked to nutritional and socioeconomic factors and causes low iron levels in the blood. Participants will be randomly assigned to one of two groups. Group A will receive Ferrous sulphate syrup at a dose of 6 mgkgday of elemental iron once daily for 8 weeks. Group B will receive Iron Polymaltose complex at the same dose and frequency for 8 weeks. Both treatments are given orally, and the study is designed to compare these two active treatments in a single-masked way. During the 8-week treatment period, researchers will monitor the increase in hemoglobin levels as the primary outcome measure. Participants will be evaluated for treatment response and any side effects. The study includes children with iron deficiency anemia, and participants progress will be observed through medical history and clinical assessments. The total participation duration aligns with the 8-week treatment period.

Comparison Of Efficacy Of Iron Polymaltose Complex And Ferrous Sulphate In Iron Deficiency Anemia In Pediatric Patients